Did you know? According to a systematic review of Iron Deficiency Anaemia (IDA) among pregnant women in Malaysia, its numbers range from 19.3% to 57.4%1.
But despite how common it is, many women who have IDA often may not know they suffer from it.
What is IDA
It is basically a common type of anaemia where the body does not contain enough sufficient iron to produce sufficient haemoglobin. Haemoglobin is the important protein in your red blood cells that is responsible to carry oxygen across your whole body.
What Are the Symptoms of IDA
One of the best ways to know if you have IDA is to confirm it with your doctor. But first, take note of the possible symptoms.
They include fatigue, loss of stamina, shortness of breath, weakness, and light-headedness. If people are telling you that you are getting pale, that might be a sign for you to double-check with your doctor.
So, take a few days to be aware of what your body is telling you. Your quality of life may be affected by the symptoms of untreated iron deficiency anaemia.
Iberet® Folic 500 is an oral iron preparation indicated in pregnancy for the prevention and treatment of iron deficiency anemia where there is a concomitant deficient intake or increased need for the B-complex vitamins (including folic acid)3.
Iberet® Folic 500 helps fight symptoms of iron deficiency anaemia with special technology:
- 105mg optimal dose of elemental iron
- Vitamins C to help support iron absorption
- A supplement formulated with special sustained release Gradumet® Technology that releases the iron at the duodenum for better iron absorption and lesser gastric irritation.
For more information, please visit https://www.iberet.my.
References:
- Abd Rahman, R., Idris, I. B., Isa, Z. M., Rahman, R. A., & Mahdy, Z. A. (2022, April 15). The prevalence and risk factors of iron deficiency anemia among pregnant women in Malaysia: A systematic review. Frontiers in nutrition. Retrieved February 6, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051477/
- Iberet Malaysia PI, Oct 2022
KKLIU 0316/2023 (Exp: 31 December 2025)